We are live on ! Find out more
EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of EGRX yet.

EGRX Hedge Fund Activity: Q1 2026 in Review

2 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Eagle Pharmaceuticals, Inc. (EGRX) for Q1 2026, worth a combined $4.21K — down 51% from $8.64K a quarter earlier.

Fund positioning in EGRX was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Eagle Pharmaceuticals, Inc. (EGRX) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $4.21K of Eagle Pharmaceuticals, Inc. stock for Q1 2026, down 51% quarter-over-quarter.
  • 0 funds opened new Eagle Pharmaceuticals, Inc. positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.